Sanford Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanford Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3349
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, 3D mammography, breast radiology, cancer risk assessment and cancer screenings, among others. It carries out research in cancer biology and immunotherapies, cellular therapies and stem cell biology, diabetes, enabling technologies, environmental influences on health and disease, genetics and genomics, pediatrics and rare diseases, population health. The center serves across the US. Sanford is headquartered in Sioux Falls, South Dakota, the US.

Sanford Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanford Health, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InGeneron Raises USD20 Million in Series D Financing 11
Partnerships 12
Caladrius Biosciences Enters into Development Agreement with Sanford Research 12
Merger 13
Sanford Health Completes Merger With Medcenter One 13
Equity Offering 14
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 14
Caladrius Biosciences Raises USD6.6 Million in Private Placement of Shares 16
Acquisition 18
Sanford Health Acquires Hematech, Drug Development Company 18
Sanford Health Completes Acquisition Of Hillsboro Medical Center 19
Sanford Health – Key Competitors 20
Sanford Health – Key Employees 21
Sanford Health – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Recent Developments 24
Strategy And Business Planning 24
Jan 23, 2018: Sanford Health increases global presence with expansion in seven countries 24
Legal and Regulatory 25
Oct 20, 2017: FDA-approved clinical trial tests stem cells to heal wounds 25
Government and Public Interest 26
Sep 15, 2017: Sanford Health awarded $1.8 million to study brain tumors 26
Aug 18, 2017: Sanford Health granted $11 million to study population health 27
Product News 28
Dec 04, 2017: Breast cancer study uses personalized approach 28
Apr 20, 2017: Oncology group chooses Sanford for first clinical trial 29
Other Significant Developments 30
Apr 17, 2018: Personalized Medicine Initiatives Offer Hope To Acutely Ill Children At Nicklaus Children’s Hospital 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sanford Health, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InGeneron Raises USD20 Million in Series D Financing 11
Caladrius Biosciences Enters into Development Agreement with Sanford Research 12
Sanford Health Completes Merger With Medcenter One 13
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 14
Caladrius Biosciences Raises USD6.6 Million in Private Placement of Shares 16
Sanford Health Acquires Hematech, Drug Development Company 18
Sanford Health Completes Acquisition Of Hillsboro Medical Center 19
Sanford Health, Key Competitors 20
Sanford Health, Key Employees 21
Sanford Health, Other Locations 22
Sanford Health, Subsidiaries 23
Sanford Health, Joint Venture 23

List of Figures
Sanford Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sanford Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Vozrozhdenie Bank (VZRZ):企業の財務・戦略的SWOT分析
    Summary Vozrozhdenie Bank (VB) is a banking service provider that provides corporate business, retail business, bank cards transactions and financial market operations. The company provides personal banking and business services. It products include debit and credit cards, accounts, and others. VB o …
  • Kangwon Land Inc.:企業の戦略・SWOT・財務情報
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Molex LLC:医療機器:M&Aディール及び事業提携情報
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …
  • Imperial Oil Ltd (IMO):企業の財務・戦略的SWOT分析
    Imperial Oil Ltd (IMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CSX Corporation, Inc.:企業の戦略・SWOT・財務情報
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zenrosai:企業の戦略・SWOT・財務情報
    Zenrosai - Strategy, SWOT and Corporate Finance Report Summary Zenrosai - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Accelovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization's CRO services inc …
  • Tri-County Rural Electric Cooperative Inc:企業の戦略的SWOT分析
    Tri-County Rural Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Aptiv Plc:企業の戦略・SWOT・財務分析
    Aptiv Plc - Strategy, SWOT and Corporate Finance Report Summary Aptiv Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Aegerion Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aegerion Pharmaceuticals Inc (Aegerion) is a pharmaceutical company that develops therapies for patients with debilitating often fatal and rare diseases. The company provides therapeutics to treat severe inherited lipid disorders. Its therapeutic focus comprise homozygous familial hyperchole …
  • Shoaibi Group:石油・ガス:M&Aディール及び事業提携情報
    Summary Shoaibi Group (Shoaibi) is a provider of manufacturing, services, product distribution and investment programs. The company provides active venture capital and private equity investments. It offers services such as marketing and technical services, finance and taxation, public relations, adm …
  • Acerus Pharmaceuticals Corp (ASP):製薬・医療:M&Aディール及び事業提携情報
    Summary Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing men’s and women’s health. The company uses its proprietary drug delivery technology platforms, which in …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company's product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medica …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AngloGold Ashanti Limited:戦略・SWOT・企業財務分析
    AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆